| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF703 ZNF536 HIVEP1 HIPK2 DAP IRX1 ZEB2 TRIM66 NCOR2 MAPK15 NKX2-1 NR0B1 PRDM12 CCAR2 OLIG2 TCF7L1 MNT HOXB13 NOTCH2 ZNF541 NCK2 FOXC2 | 3.43e-07 | 1399 | 96 | 22 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF703 ZNF536 HIVEP1 HIPK2 DAP IRX1 ZEB2 TRIM66 NCOR2 MAPK15 NKX2-1 NR0B1 PRDM12 CCAR2 OLIG2 TCF7L1 MNT HOXB13 NOTCH2 ZNF541 NCK2 FOXC2 | 4.06e-07 | 1413 | 96 | 22 | GO:1902679 |
| GeneOntologyBiologicalProcess | neuron development | CHL1 PDZD7 DBN1 ATAT1 THOC2 CIT ZEB2 NKX2-1 LZTS1 PRDM12 FEV RP1 SEMA4A CAMSAP1 PARD3 OLIG2 CNGB1 PALLD NOTCH2 NCK2 | 1.08e-05 | 1463 | 96 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ZNF703 AMPD2 SIPA1L3 PDZD7 ZEB2 NCOR2 NKX2-1 TJP1 NR0B1 KAZN PARD3 PALLD HOXB13 NOTCH2 FOXC2 | 1.13e-05 | 870 | 96 | 15 | GO:0030855 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ZNF536 HIVEP1 HIPK2 IRX1 ZEB2 NCOR2 MAPK15 NKX2-1 NR0B1 PRDM12 OLIG2 MNT HOXB13 NOTCH2 NCK2 FOXC2 | 2.67e-05 | 1053 | 96 | 16 | GO:0000122 |
| GeneOntologyBiologicalProcess | epithelial cell development | 3.71e-05 | 269 | 96 | 8 | GO:0002064 | |
| GeneOntologyBiologicalProcess | protein kinase C signaling | 3.91e-05 | 41 | 96 | 4 | GO:0070528 | |
| GeneOntologyBiologicalProcess | epithelium development | ZNF703 AMPD2 SIPA1L3 PDZD7 IRX1 ZEB2 MYSM1 SLC22A6 NCOR2 NKX2-1 TJP1 NR0B1 KAZN CSMD1 PARD3 PALLD HOXB13 NOTCH2 FOXC2 | 4.01e-05 | 1469 | 96 | 19 | GO:0060429 |
| GeneOntologyBiologicalProcess | podocyte differentiation | 1.41e-04 | 22 | 96 | 3 | GO:0072112 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell differentiation | 1.41e-04 | 22 | 96 | 3 | GO:0072311 | |
| GeneOntologyBiologicalProcess | renal filtration cell differentiation | 1.41e-04 | 22 | 96 | 3 | GO:0061318 | |
| GeneOntologyBiologicalProcess | glomerular epithelium development | 1.62e-04 | 23 | 96 | 3 | GO:0072010 | |
| GeneOntologyBiologicalProcess | neuron projection development | CHL1 PDZD7 DBN1 THOC2 CIT ZEB2 NKX2-1 LZTS1 PRDM12 SEMA4A CAMSAP1 PARD3 OLIG2 PALLD NOTCH2 NCK2 | 2.74e-04 | 1285 | 96 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | nephron epithelium development | 3.31e-04 | 128 | 96 | 5 | GO:0072009 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 3.46e-04 | 372 | 96 | 8 | GO:0060485 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 3.64e-04 | 579 | 96 | 10 | GO:0051493 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 3.79e-04 | 582 | 96 | 10 | GO:0044089 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SPHK2 SYNPO2 DBN1 ATAT1 ZDHHC1 MAPK15 LZTS1 TJP1 RP1 SEMA4A CAMSAP1 SLX4 PSRC1 NCK2 FOXC2 | 3.79e-04 | 1189 | 96 | 15 | GO:0044087 |
| Domain | NPIP | 4.60e-05 | 14 | 96 | 3 | IPR009443 | |
| Domain | SANT_dom | 3.14e-04 | 26 | 96 | 3 | IPR017884 | |
| Domain | SANT | 3.93e-04 | 28 | 96 | 3 | PS51293 | |
| Domain | Ig_I-set | 4.45e-04 | 190 | 96 | 6 | IPR013098 | |
| Domain | I-set | 4.45e-04 | 190 | 96 | 6 | PF07679 | |
| Domain | Myb_DNA-binding | 7.64e-04 | 35 | 96 | 3 | PF00249 | |
| Domain | PDZ | 8.05e-04 | 141 | 96 | 5 | PF00595 | |
| Domain | MYB_LIKE | 9.74e-04 | 38 | 96 | 3 | PS50090 | |
| Domain | PDZ | 1.00e-03 | 148 | 96 | 5 | SM00228 | |
| Domain | - | 1.06e-03 | 150 | 96 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.09e-03 | 151 | 96 | 5 | PS50106 | |
| Domain | PDZ | 1.13e-03 | 152 | 96 | 5 | IPR001478 | |
| Domain | IGc2 | 1.34e-03 | 235 | 96 | 6 | SM00408 | |
| Domain | Ig_sub2 | 1.34e-03 | 235 | 96 | 6 | IPR003598 | |
| Domain | Homeodomain-like | 1.62e-03 | 332 | 96 | 7 | IPR009057 | |
| Domain | JAB_MPN | 1.67e-03 | 12 | 96 | 2 | SM00232 | |
| Domain | JAMM/MPN+_dom | 1.67e-03 | 12 | 96 | 2 | IPR000555 | |
| Domain | JAB | 1.67e-03 | 12 | 96 | 2 | PF01398 | |
| Domain | SANT | 2.17e-03 | 50 | 96 | 3 | SM00717 | |
| Domain | SANT/Myb | 2.42e-03 | 52 | 96 | 3 | IPR001005 | |
| Domain | AT_hook | 2.99e-03 | 16 | 96 | 2 | PF02178 | |
| Domain | Ig-like_fold | CHL1 SIGLEC12 LILRB3 VASN SPEG IGSF10 CSF2RB SIGLEC1 SEMA4A PALLD | 3.38e-03 | 706 | 96 | 10 | IPR013783 |
| Domain | - | 3.41e-03 | 283 | 96 | 6 | 1.10.10.60 | |
| Domain | IG | 6.01e-03 | 421 | 96 | 7 | SM00409 | |
| Domain | Ig_sub | 6.01e-03 | 421 | 96 | 7 | IPR003599 | |
| Domain | PHD | 6.80e-03 | 75 | 96 | 3 | PF00628 | |
| Domain | Znf_FYVE_PHD | 6.99e-03 | 147 | 96 | 4 | IPR011011 | |
| Domain | DHHC | 7.26e-03 | 25 | 96 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 7.26e-03 | 25 | 96 | 2 | IPR001594 | |
| Domain | Znf_PHD-finger | 7.85e-03 | 79 | 96 | 3 | IPR019787 | |
| Domain | AT_hook | 8.44e-03 | 27 | 96 | 2 | SM00384 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 4.00e-09 | 184 | 102 | 9 | 32908313 | |
| Pubmed | AMPD2 SIPA1L3 DIDO1 DBN1 HUWE1 CIT ZEB2 AKAP12 NCOR2 PELP1 LZTS1 TJP1 CCAR2 BSN CAMSAP1 PARD3 | 2.16e-08 | 963 | 102 | 16 | 28671696 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIVEP1 IRX1 ZEB2 MYSM1 NKX2-1 NR0B1 SP6 PRDM12 FEV OLIG2 TCF7L1 MNT HOXB13 ZNF541 FOXC2 | 6.71e-08 | 908 | 102 | 15 | 19274049 |
| Pubmed | ZNF536 HIVEP1 POLRMT CCDC85C HUWE1 ZEB2 PRR12 NCOR2 NR0B1 CAMSAP1 | 4.50e-07 | 418 | 102 | 10 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 SPHK2 SPEG SIPA1L3 POLRMT HUWE1 ZNF865 CIT PRR12 KMT2C NCOR2 CAMSAP1 HOXB13 NOTCH2 NCK2 | 8.15e-07 | 1105 | 102 | 15 | 35748872 |
| Pubmed | ZNF703 ZNF536 HIVEP1 HIPK2 CCDC85C DIDO1 DBN1 CIT ZEB2 PRR12 KMT2C NCOR2 CCAR2 FEV TAF1L MNT SLX4 | 8.67e-07 | 1429 | 102 | 17 | 35140242 | |
| Pubmed | ZNF536 HIVEP1 DIDO1 KMT2C NKX2-1 NR0B1 SP6 MPND TCF7L1 MNT HOXB13 FOXC2 | 1.19e-06 | 709 | 102 | 12 | 22988430 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMPD2 HIVEP1 SIPA1L3 CCDC85C ATAT1 ARHGEF17 GLCCI1 TJP1 CAMSAP1 PARD3 PALLD NOTCH2 TNS3 | 1.48e-06 | 861 | 102 | 13 | 36931259 |
| Pubmed | 4.22e-06 | 81 | 102 | 5 | 20301590 | ||
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 5.88e-06 | 40 | 102 | 4 | 27657450 | |
| Pubmed | 5.95e-06 | 233 | 102 | 7 | 37704626 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAN1C1 KIZ SIPA1L3 HIPK2 CCDC85C ADGRG1 DAP HUWE1 ATAT1 KMT2C NCOR2 TJP1 CSMD1 PARD3 NOTCH2 NCK2 | 6.90e-06 | 1489 | 102 | 16 | 28611215 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF536 POLRMT HUWE1 ZEB2 NCOR2 PELP1 CCAR2 CAMSAP1 MNT HOXB13 NOTCH2 FOXC2 | 8.24e-06 | 857 | 102 | 12 | 25609649 |
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 8.52e-06 | 2 | 102 | 2 | 33824309 | |
| Pubmed | Ccdc85c-Par3 condensates couple cell polarity with Notch to control neural progenitor proliferation. | 8.52e-06 | 2 | 102 | 2 | 37352102 | |
| Pubmed | The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes. | 8.52e-06 | 2 | 102 | 2 | 18786356 | |
| Pubmed | Par3 and ZO-1 Membrane Clustering is an Indicator of Poor Prognosis in Lung Squamous Cell Carcinoma. | 8.52e-06 | 2 | 102 | 2 | 34216486 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31239441 | ||
| Pubmed | 8.66e-06 | 162 | 102 | 6 | 25826454 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.56e-06 | 351 | 102 | 8 | 38297188 | |
| Pubmed | 1.44e-05 | 104 | 102 | 5 | 9205841 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 SFSWAP DIDO1 DBN1 HUWE1 THOC2 NCOR2 USP42 CCAR2 PARD3 NOTCH2 | 1.75e-05 | 774 | 102 | 11 | 15302935 |
| Pubmed | AMPD2 BMP2K HIPK2 DIDO1 UNC13D HUWE1 THOC2 AKAP12 KMT2C TMEM131 PARD3 QSOX2 SLX4 | 1.75e-05 | 1084 | 102 | 13 | 11544199 | |
| Pubmed | 1.80e-05 | 503 | 102 | 9 | 16964243 | ||
| Pubmed | 2.20e-05 | 191 | 102 | 6 | 24146773 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 27905023 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23601688 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11438542 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 2.55e-05 | 3 | 102 | 2 | 11948212 | |
| Pubmed | 2.64e-05 | 118 | 102 | 5 | 30979931 | ||
| Pubmed | 3.56e-05 | 549 | 102 | 9 | 38280479 | ||
| Pubmed | BMP2K SIPA1L3 CCDC85C AKAP12 TJP1 CCAR2 TMEM131 PALLD QSOX2 PSRC1 NOTCH2 NCK2 | 4.02e-05 | 1007 | 102 | 12 | 34597346 | |
| Pubmed | Crumbs3 is essential for proper epithelial development and viability. | 4.74e-05 | 24 | 102 | 3 | 24164893 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 35240198 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23406467 | ||
| Pubmed | Ventromedian forebrain dysgenesis follows early prenatal ethanol exposure in mice. | 5.09e-05 | 4 | 102 | 2 | 21074610 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26231217 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12637565 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12771131 | ||
| Pubmed | Formation and contraction of multicellular actomyosin cables facilitate lens placode invagination. | 5.09e-05 | 4 | 102 | 2 | 32113830 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 19640478 | ||
| Pubmed | 5.26e-05 | 446 | 102 | 8 | 24255178 | ||
| Pubmed | Centrosome anchoring regulates progenitor properties and cortical formation. | 5.37e-05 | 25 | 102 | 3 | 32238932 | |
| Pubmed | Ofd1 controls dorso-ventral patterning and axoneme elongation during embryonic brain development. | 6.06e-05 | 26 | 102 | 3 | 23300826 | |
| Pubmed | 6.06e-05 | 26 | 102 | 3 | 29899142 | ||
| Pubmed | 6.10e-05 | 335 | 102 | 7 | 15741177 | ||
| Pubmed | 6.27e-05 | 591 | 102 | 9 | 15231748 | ||
| Pubmed | 6.81e-05 | 27 | 102 | 3 | 27178982 | ||
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 8.47e-05 | 5 | 102 | 2 | 21285352 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 30217225 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 15084279 | ||
| Pubmed | Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. | 8.47e-05 | 5 | 102 | 2 | 11171336 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 22028439 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 27084580 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 15778499 | ||
| Pubmed | ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. | 8.47e-05 | 5 | 102 | 2 | 21328542 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 35283834 | ||
| Pubmed | SFSWAP BMP2K HUWE1 ZNF865 AKAP12 TJP1 CCAR2 CAMSAP1 PARD3 NOTCH2 | 9.80e-05 | 777 | 102 | 10 | 35844135 | |
| Pubmed | 1.04e-04 | 31 | 102 | 3 | 23312518 | ||
| Pubmed | Regulation of lung endoderm progenitor cell behavior by miR302/367. | 1.14e-04 | 32 | 102 | 3 | 21350014 | |
| Pubmed | 1.18e-04 | 85 | 102 | 4 | 23648065 | ||
| Pubmed | PAR3 restricts the expansion of neural precursor cells by regulating hedgehog signaling. | 1.25e-04 | 33 | 102 | 3 | 36218069 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 26859354 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 22868911 | ||
| Pubmed | Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon. | 1.27e-04 | 6 | 102 | 2 | 11493571 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 12953056 | ||
| Pubmed | Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. | 1.27e-04 | 6 | 102 | 2 | 20709820 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 17634372 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 18582453 | ||
| Pubmed | Non-cell autonomous and non-catalytic activities of ATX in the developing brain. | 1.27e-04 | 6 | 102 | 2 | 25788872 | |
| Pubmed | Genome-wide association study of antibody response to smallpox vaccine. | 1.37e-04 | 34 | 102 | 3 | 22542470 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 1.47e-04 | 90 | 102 | 4 | 15616553 | |
| Pubmed | Developmental diversification of cortical inhibitory interneurons. | 1.53e-04 | 91 | 102 | 4 | 29513653 | |
| Pubmed | 1.72e-04 | 396 | 102 | 7 | 26687479 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 19551907 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 28369449 | ||
| Pubmed | The embryonic preoptic area is a novel source of cortical GABAergic interneurons. | 1.77e-04 | 7 | 102 | 2 | 19625528 | |
| Pubmed | Cell surface tumor endothelial markers are conserved in mice and humans. | 1.77e-04 | 7 | 102 | 2 | 11559528 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.77e-04 | 398 | 102 | 7 | 35016035 | |
| Pubmed | PRC1 sustains the integrity of neural fate in the absence of PRC2 function. | 1.92e-04 | 38 | 102 | 3 | 34994686 | |
| Pubmed | 2.24e-04 | 40 | 102 | 3 | 26657772 | ||
| Pubmed | 2.24e-04 | 40 | 102 | 3 | 23362348 | ||
| Pubmed | 2.24e-04 | 40 | 102 | 3 | 30865227 | ||
| Pubmed | Association of ASIP/mPAR-3 with adherens junctions of mouse neuroepithelial cells. | 2.36e-04 | 8 | 102 | 2 | 12203721 | |
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 16331648 | ||
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 38419656 | ||
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 22006950 | ||
| Pubmed | FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex. | 2.36e-04 | 8 | 102 | 2 | 20080746 | |
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 22512338 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 2.66e-04 | 565 | 102 | 8 | 25468996 | |
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 2.75e-04 | 106 | 102 | 4 | 31024071 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.86e-04 | 724 | 102 | 9 | 36232890 | |
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 27487469 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 12515806 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 34287339 | ||
| Pubmed | Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia. | 3.03e-04 | 9 | 102 | 2 | 17260385 | |
| Pubmed | The hedgehog co-receptor BOC differentially regulates SHH signaling during craniofacial development. | 3.03e-04 | 9 | 102 | 2 | 33060130 | |
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 21074722 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 11257119 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 25057126 | ||
| Interaction | PAX8 interactions | 7.41e-08 | 111 | 99 | 8 | int:PAX8 | |
| Interaction | TEAD1 interactions | 2.12e-07 | 176 | 99 | 9 | int:TEAD1 | |
| Interaction | GSC interactions | 2.36e-07 | 87 | 99 | 7 | int:GSC | |
| Interaction | DYRK1A interactions | SIPA1L3 HIPK2 DBN1 HUWE1 ARHGEF17 CIT GLCCI1 TRIM66 NCOR2 LZTS1 CAMSAP1 PALLD SLX4 NOTCH2 | 5.09e-07 | 552 | 99 | 14 | int:DYRK1A |
| Interaction | ERG interactions | 1.55e-06 | 223 | 99 | 9 | int:ERG | |
| Interaction | TBXT interactions | 1.68e-06 | 116 | 99 | 7 | int:TBXT | |
| Interaction | TBR1 interactions | 1.99e-05 | 113 | 99 | 6 | int:TBR1 | |
| Interaction | GCM1 interactions | 2.11e-05 | 68 | 99 | 5 | int:GCM1 | |
| Interaction | YWHAH interactions | AMPD2 HIVEP1 SFSWAP SPEG SIPA1L3 CCDC85C HUWE1 ATAT1 ARHGEF17 GLCCI1 TJP1 CCAR2 CAMSAP1 PARD3 PALLD NOTCH2 TNS3 | 2.43e-05 | 1102 | 99 | 17 | int:YWHAH |
| Interaction | TLX1 interactions | 2.51e-05 | 175 | 99 | 7 | int:TLX1 | |
| Interaction | RCOR1 interactions | AMPD2 ZNF536 HIVEP1 POLRMT CCDC85C HUWE1 ZEB2 TRIM66 NCOR2 NKX2-1 CAMSAP1 | 3.10e-05 | 494 | 99 | 11 | int:RCOR1 |
| Interaction | FOXL1 interactions | 5.17e-05 | 196 | 99 | 7 | int:FOXL1 | |
| Interaction | GATA2 interactions | 5.69e-05 | 199 | 99 | 7 | int:GATA2 | |
| Interaction | PAX2 interactions | 6.21e-05 | 85 | 99 | 5 | int:PAX2 | |
| Interaction | FEV interactions | 6.46e-05 | 203 | 99 | 7 | int:FEV | |
| Interaction | FOXI1 interactions | 9.06e-05 | 92 | 99 | 5 | int:FOXI1 | |
| Interaction | NANOG interactions | DIDO1 HUWE1 ZNF865 KMT2C NCOR2 PELP1 USP42 NR0B1 CCAR2 TCF7L1 | 1.28e-04 | 481 | 99 | 10 | int:NANOG |
| Interaction | ODF2 interactions | 1.30e-04 | 158 | 99 | 6 | int:ODF2 | |
| Cytoband | 16p12.2 | 7.83e-05 | 37 | 102 | 3 | 16p12.2 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.89e-05 | 161 | 67 | 6 | 593 | |
| GeneFamily | PDZ domain containing | 2.50e-04 | 152 | 67 | 5 | 1220 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.98e-04 | 53 | 67 | 3 | 532 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 2.71e-03 | 21 | 67 | 2 | 680 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN | 1.10e-06 | 200 | 101 | 8 | M7751 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_UP | 2.48e-05 | 149 | 101 | 6 | M2968 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP | 2.88e-05 | 153 | 101 | 6 | M8249 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | ZNF703 ADAMTS5 IRX1 PIGV ZEB2 NKX2-1 NR0B1 PRDM12 FEV CSMD1 PARD3 OLIG2 HOXB13 NOTCH2 | 4.30e-05 | 1035 | 101 | 14 | M9898 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 5.02e-05 | 338 | 101 | 8 | M17094 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 5.30e-05 | 441 | 101 | 9 | M172 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 6.49e-05 | 177 | 101 | 6 | M39245 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | ZNF536 HIPK2 CCDC85C GLCCI1 USP42 TMEM131 PARD3 TCF7L1 NOTCH2 | 7.94e-10 | 199 | 101 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.88e-08 | 200 | 101 | 8 | 55ac281901309e30978da1f7489386e54489721e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-07 | 188 | 101 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 191 | 101 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 191 | 101 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-07 | 192 | 101 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 3.14e-07 | 195 | 101 | 7 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 196 | 101 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.25e-07 | 196 | 101 | 7 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.25e-07 | 196 | 101 | 7 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-07 | 197 | 101 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.49e-07 | 198 | 101 | 7 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.49e-07 | 198 | 101 | 7 | 86a4c8e859ce11a95875f8844963baeb1ba898ec | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.49e-07 | 198 | 101 | 7 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-07 | 199 | 101 | 7 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-07 | 199 | 101 | 7 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 3.61e-07 | 199 | 101 | 7 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.73e-07 | 200 | 101 | 7 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-06 | 164 | 101 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-06 | 177 | 101 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.84e-06 | 183 | 101 | 6 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-06 | 185 | 101 | 6 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-06 | 185 | 101 | 6 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 186 | 101 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-06 | 186 | 101 | 6 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-06 | 187 | 101 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-06 | 188 | 101 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.48e-06 | 188 | 101 | 6 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-06 | 189 | 101 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-06 | 189 | 101 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-06 | 189 | 101 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.76e-06 | 190 | 101 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-06 | 190 | 101 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.76e-06 | 190 | 101 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.91e-06 | 191 | 101 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-06 | 191 | 101 | 6 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.91e-06 | 191 | 101 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-06 | 191 | 101 | 6 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.91e-06 | 191 | 101 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 191 | 101 | 6 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 5.06e-06 | 192 | 101 | 6 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 192 | 101 | 6 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-06 | 193 | 101 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.36e-06 | 194 | 101 | 6 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.52e-06 | 195 | 101 | 6 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-06 | 196 | 101 | 6 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 5.69e-06 | 196 | 101 | 6 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-06 | 196 | 101 | 6 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 197 | 101 | 6 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 197 | 101 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-06 | 197 | 101 | 6 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 197 | 101 | 6 | 8b3bf5b45e49bf1c60e4d2703b470bb890385f67 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 197 | 101 | 6 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 197 | 101 | 6 | 77fe092aae8f05fe137680506892d2f61071d6ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 197 | 101 | 6 | 02e70768a917c5f097bc653e9e965a1000289d2e | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 197 | 101 | 6 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 197 | 101 | 6 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-06 | 198 | 101 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 198 | 101 | 6 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-06 | 198 | 101 | 6 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.03e-06 | 198 | 101 | 6 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | 18-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 6.21e-06 | 199 | 101 | 6 | 9dd130c041beaa319727f9d22b3f45ba0da49487 | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 199 | 101 | 6 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.21e-06 | 199 | 101 | 6 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.21e-06 | 199 | 101 | 6 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 199 | 101 | 6 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.21e-06 | 199 | 101 | 6 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.21e-06 | 199 | 101 | 6 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.21e-06 | 199 | 101 | 6 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.21e-06 | 199 | 101 | 6 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.21e-06 | 199 | 101 | 6 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.21e-06 | 199 | 101 | 6 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.39e-06 | 200 | 101 | 6 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.39e-06 | 200 | 101 | 6 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.39e-06 | 200 | 101 | 6 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.39e-06 | 200 | 101 | 6 | 1b5ac5b3ddd4df32e940531cc020998f8cd95c2c | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.39e-06 | 200 | 101 | 6 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.39e-06 | 200 | 101 | 6 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.39e-06 | 200 | 101 | 6 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.94e-06 | 54 | 101 | 4 | 98b31718fa200432cf86b59a52484da101219f96 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.94e-06 | 54 | 101 | 4 | 872e7374dac64be2c8ebe71e88a2ec6814168d89 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-05 | 153 | 101 | 5 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.03e-05 | 158 | 101 | 5 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.31e-05 | 161 | 101 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.41e-05 | 162 | 101 | 5 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 3.83e-05 | 166 | 101 | 5 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 171 | 101 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 4.54e-05 | 172 | 101 | 5 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 172 | 101 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.66e-05 | 173 | 101 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-05 | 175 | 101 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-05 | 175 | 101 | 5 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-05 | 175 | 101 | 5 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 177 | 101 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.20e-05 | 177 | 101 | 5 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 177 | 101 | 5 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| Disease | Retinitis Pigmentosa | 2.58e-05 | 104 | 98 | 5 | C0035334 | |
| Disease | lumbar disc degeneration | 1.10e-04 | 28 | 98 | 3 | EFO_0004994 | |
| Disease | Retinitis pigmentosa | 1.10e-04 | 74 | 98 | 4 | cv:C0035334 | |
| Disease | serum gamma-glutamyl transferase measurement | PLB1 SIPA1L3 CIT NCOR2 TJP1 RP1 SIGLEC1 CSMD1 PARD3 PSRC1 NOTCH2 | 2.28e-04 | 914 | 98 | 11 | EFO_0004532 |
| Disease | eosinophil count | PLB1 HIVEP1 SIPA1L3 UNC13D THOC2 GLCCI1 NCOR2 CSF2RB PELP1 MED22 TMEM131 OLIG2 NOTCH2 NCK2 | 3.98e-04 | 1488 | 98 | 14 | EFO_0004842 |
| Disease | hair color | 6.10e-04 | 311 | 98 | 6 | EFO_0003924 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.06e-03 | 60 | 98 | 3 | C4722327 | |
| Disease | urate measurement, bone density | 1.08e-03 | 619 | 98 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Prostate cancer, familial | 1.59e-03 | 69 | 98 | 3 | C2931456 | |
| Disease | Bone marrow hypocellularity | 1.61e-03 | 18 | 98 | 2 | C1855710 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 1.61e-03 | 18 | 98 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | coronary artery disease | 2.04e-03 | 1194 | 98 | 11 | EFO_0001645 | |
| Disease | neutrophil count | SPHK2 HIVEP1 PIGV CIT GLCCI1 AKAP12 MED22 RP1 SEMA4A TCF7L1 NOTCH2 TNS3 | 2.09e-03 | 1382 | 98 | 12 | EFO_0004833 |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 2.42e-03 | 22 | 98 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | cleft lip | 2.61e-03 | 284 | 98 | 5 | EFO_0003959 | |
| Disease | reticulocyte measurement | 2.63e-03 | 1053 | 98 | 10 | EFO_0010700 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFPLSQPFSLHHPSR | 266 | Q8N163 | |
| LDQRFPENHPTHSSP | 171 | Q8NDL9 | |
| PPAAAQVAHQKPHAS | 71 | P51397 | |
| IPHACRQPETPAHAD | 3271 | Q96PZ7 | |
| AHPQEPAESAHEPRL | 356 | Q02952 | |
| HAPAHSNPSGRAALA | 221 | Q9UNA0 | |
| LAQACQPPPAHAHAA | 131 | Q99581 | |
| QPPPAHAHAAAAAAA | 136 | Q99581 | |
| AAAPKLRAPSHHAQL | 2566 | Q8IYW2 | |
| SQHSPTRPPVAAAAA | 76 | Q86VQ1 | |
| VSADAPVHPPALEQH | 291 | Q01433 | |
| KNVDSLSAPHNHPPE | 661 | Q9NSY1 | |
| TRPASQPTPFALHHA | 466 | Q5T5Y3 | |
| HPHPSTPATARQQIA | 1301 | O14578 | |
| AALAHPQESHPFPES | 506 | Q16671 | |
| QSPDLAHHAASPAAL | 326 | P43699 | |
| SRHLPSVSSLPFHPQ | 711 | Q92617 | |
| GPRPALPESLHHSLD | 616 | Q6ZRP7 | |
| SRHLPSVSSLPFHPQ | 631 | F8W0I5 | |
| EALPPPATAHRNFHL | 891 | Q96PE2 | |
| IARTPAKNLAPHHAS | 1991 | Q9Y618 | |
| AKNLAPHHASPDPPA | 1996 | Q9Y618 | |
| TAAPPAPVHAQHALS | 2186 | Q04721 | |
| SHPPHPADRQAVRVS | 296 | Q674X7 | |
| PHPAVNESFAHPSRA | 2101 | Q8NEZ4 | |
| HLAAAAAAAHLPTQP | 1086 | Q9H2X6 | |
| SPESASHQLHPAPPD | 141 | Q9Y250 | |
| SDHHETPPAAPDRNP | 701 | O00533 | |
| SDGPALHPAHAPQIS | 256 | O43639 | |
| VSPSQAHLHKPRADP | 361 | Q8TD08 | |
| PSAGPLQVAAPAHSH | 176 | Q15528 | |
| QLHSPALSPAHSPAK | 241 | Q9UPA5 | |
| RHEARPHSQPSSAPA | 3676 | Q9UPA5 | |
| SLDDLSAPPHHRSIP | 246 | A6NKD9 | |
| SAPPHHRSIPNGLHD | 251 | A6NKD9 | |
| ADHLPAHQPLDAAPV | 971 | Q9H5P4 | |
| HIAHIAPSAPSPAVQ | 466 | Q99583 | |
| SRHLPSVSSLPFHPQ | 626 | A8MRT5 | |
| SRHLPSVSSLPFHPQ | 836 | A8MRT5 | |
| SPDGSLPEHHAAAPN | 251 | Q99958 | |
| SSNPHLLSHPSEPLE | 401 | O75022 | |
| PSPFNHRPGSHLDSH | 311 | Q16643 | |
| ALPAPHAHAPALAAA | 336 | Q9H4Q4 | |
| LSHRSDPNAVAPAPQ | 46 | Q6PGN9 | |
| HPHSPALPSLQDIDA | 351 | Q8N594 | |
| QPTKNFSIPDPHSHR | 181 | Q2M2Z5 | |
| SRHLPSVSSLPFHPQ | 631 | C9JG80 | |
| SRHLPSVSSLPFHPQ | 841 | C9JG80 | |
| SAVAPVHPPNRSAPH | 51 | Q8IZL8 | |
| ATAPPPRSNHAAEEA | 711 | Q7Z6Z7 | |
| HHLAPPAEARKVPSA | 341 | P51843 | |
| SRHLPSVSSLPFHPQ | 641 | E5RHQ5 | |
| SRHLPSVSSLPFHPQ | 851 | E5RHQ5 | |
| KSHPQPHSALHFPAA | 256 | Q8WX93 | |
| PHTAAHSQFPIPRNS | 986 | Q6WRI0 | |
| HTRHHCQIPVPDPAT | 301 | P32927 | |
| PESPAFSRHADPAHQ | 156 | A4D1S0 | |
| ASLPPASQASNHRDP | 1546 | Q9BTC0 | |
| TVHAPFPAAHPASRS | 66 | Q9Y653 | |
| EAHPLPVNHSDSSGR | 611 | Q9NR34 | |
| HSRAAAVDPTPAAPA | 206 | Q5SQI0 | |
| NLVAHSPLTSHPAAP | 26 | Q92826 | |
| AALSATVPRHEPPFH | 336 | P51172 | |
| TAAIPTHHCRPPADA | 41 | Q4U2R8 | |
| SEAPQPPEAHLPHSA | 736 | O00411 | |
| SRHLPSVSSLPFHPQ | 631 | A6NJU9 | |
| PPEQIDSHSRLPHSA | 411 | Q8TEW0 | |
| RAISAHSPPHPVAVA | 131 | P56715 | |
| APRPAAPAAHSAHSA | 876 | Q12872 | |
| RDLPNTHPFHTPVNA | 1416 | Q8IZX4 | |
| HDAVTFALQHPRPVP | 736 | Q9BXS9 | |
| APHAPAAPSALARDQ | 251 | P78414 | |
| PRHPLAPSAEQHPAS | 711 | Q9BRB3 | |
| HAVLLPADSPTAPHI | 306 | Q9H3S1 | |
| AAPHPLLSLDPHFSH | 1181 | O60292 | |
| AHPNAPATARLSSPA | 251 | Q96SF2 | |
| GLAHSAPLPAATAHP | 191 | Q13516 | |
| APLPAATAHPAAAAH | 196 | Q13516 | |
| AVHHPILPPAAAAAA | 216 | Q13516 | |
| SQHTEAPHASPPRLD | 11 | Q3SY56 | |
| PSLADPASHLPVGDH | 461 | Q8NE31 | |
| APSALHPTSVHALRP | 721 | Q6P1J6 | |
| EAHLRSHGLEPAAPS | 851 | Q9ULL5 | |
| PQAIPATNSPDHSDH | 371 | Q68CZ2 | |
| ADDSPPHHAPPALAT | 541 | Q96PQ1 | |
| PLAPHPISGDRAHFS | 1356 | Q8IY92 | |
| DQHTHPKEAATDPPA | 1171 | Q14028 | |
| AIIPDHHAEAFSPPR | 31 | Q9NUD9 | |
| HHAEAFSPPRLAPSG | 36 | Q9NUD9 | |
| HCAHREPISSSPQPV | 56 | Q7M4L6 | |
| APHALAPHPDRFSHD | 1121 | Q9H9J4 | |
| AAAASCHLHLPPPAA | 511 | Q9H7S9 | |
| SAPQSLLRHKAAHAP | 451 | P0CJ78 | |
| FHHKDPPPRNAVASV | 1186 | Q8NI27 | |
| SPDPDPNLSHDRIVH | 226 | Q9UMS6 | |
| PSHLGADLVAAPHAR | 546 | Q9NRA0 | |
| RAASSEAAPHHQPPL | 2106 | Q15772 | |
| QAHTPAPTPAKASAH | 281 | A0A1B0GUW6 | |
| LASPPSFPATLHAHQ | 556 | Q9HCS4 | |
| LSPAPLAHPSHPERA | 1321 | Q92545 | |
| APAEPHIHVLASPNA | 1581 | Q9BZZ2 | |
| PPAVHSNHAPVTQAR | 556 | Q6EMK4 | |
| SQLSHAFPELHPRPN | 41 | O15090 | |
| PPAHIAASHLSEPAK | 1371 | Q07157 | |
| LESPSHALRADAPPH | 231 | Q8N398 | |
| HALRADAPPHASSAA | 236 | Q8N398 | |
| PNHESSPHVSQALLP | 66 | O60315 | |
| PLPPSQHLASSQHES | 481 | O15016 | |
| QPPSHHFSPEQRALL | 41 | Q70J99 | |
| PSRDGSHPHQLALSD | 1186 | P15822 | |
| PAAVNAKHSRPASPD | 331 | Q8WTX9 | |
| HAHESAGQPPPSSLR | 241 | Q9H0D2 | |
| HSHPAFDPNPSLRDI | 656 | Q5VVJ2 |